215 related articles for article (PubMed ID: 9344339)
1. Immunoglobulin M antibody response to measles virus following natural virus infection, primary vaccination, and reexposure to the virus.
Nates S; Rey G; Giordano M; Medeot S; Depetris A; Boshell J; de Wolff CD
Viral Immunol; 1997; 10(3):165-73. PubMed ID: 9344339
[TBL] [Abstract][Full Text] [Related]
2. Performance and reliability of the Enzygnost measles enzyme-linked immuno-sorbent assay for detection of measles virus-specific immunoglobulin M antibody during a large measles epidemic.
Ozanne G; d'Halewyn MA
J Clin Microbiol; 1992 Mar; 30(3):564-9. PubMed ID: 1551971
[TBL] [Abstract][Full Text] [Related]
3. [Peculiarity of the laboratory diagnostic of the measles virus infection in previously vaccinated and unvaccinated patients].
Mamaeva TA; Lipskaia GIu; Naumova MA; Shul'ga SV; Mulders M; Featherstone DA; Zav'ialova LA; Chernysheva EV; Zamiatina EP; Kuznetsova NN
Vopr Virusol; 2012; 57(5):21-6. PubMed ID: 23248855
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history.
Toptygina AP; Pukhalsky AL; Alioshkin VA
Clin Diagn Lab Immunol; 2005 Jul; 12(7):845-7. PubMed ID: 16002633
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection.
Erdman DD; Heath JL; Watson JC; Markowitz LE; Bellini WJ
J Med Virol; 1993 Sep; 41(1):44-8. PubMed ID: 8228936
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the commercial ELISA test-systems of different formats to detect specific IgM and IgG in the measles patients sera].
Mamaeva TA; Naumova MA; Zheleznova NV; Lipskaia GIu; Mulders M; Featherstone DA
Vopr Virusol; 2013; 58(5):43-8. PubMed ID: 24640171
[TBL] [Abstract][Full Text] [Related]
7. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual.
Vardas E; Kreis S
J Clin Virol; 1999 Aug; 13(3):173-9. PubMed ID: 10443793
[TBL] [Abstract][Full Text] [Related]
8. Measles virus-specific IgG4 antibody titer as a serologic marker of post-vaccinal immune response.
Isa MB; MartÃnez LC; Ferreyra LJ; Giordano MO; Barril PA; Massachessi G; Nates SV
Viral Immunol; 2006; 19(2):335-9. PubMed ID: 16817776
[TBL] [Abstract][Full Text] [Related]
9. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of measles serodiagnosis during an outbreak in a vaccinated community.
Sekla L; Stackiw W; Eibisch G; Johnson I
Clin Invest Med; 1988 Aug; 11(4):304-9. PubMed ID: 3168353
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of enzyme immunoassay test for the detection of specific IgM antibodies to measles virus].
Motuzova EV; Iunasova TN; Bektimirov TA; Popov VF; Shitikova OIu
Vopr Virusol; 2008; 53(2):44-6. PubMed ID: 18450110
[TBL] [Abstract][Full Text] [Related]
13. Measles seroepidemiology among adolescents and young adults: response to revaccination.
Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
[TBL] [Abstract][Full Text] [Related]
14. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
Cohen BJ; Doblas D; Andrews N
Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
[TBL] [Abstract][Full Text] [Related]
15. Measles immunity and response to revaccination of a young adult population in Israel.
Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T
J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset.
Helfand RF; Heath JL; Anderson LJ; Maes EF; Guris D; Bellini WJ
J Infect Dis; 1997 Jan; 175(1):195-9. PubMed ID: 8985220
[TBL] [Abstract][Full Text] [Related]
17. Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination.
Helfand RF; Gary HE; Atkinson WL; Nordin JD; Keyserling HL; Bellini WJ
Clin Diagn Lab Immunol; 1998 Mar; 5(2):135-8. PubMed ID: 9521134
[TBL] [Abstract][Full Text] [Related]
18. Optimal age for measles vaccination.
Vidyashankar C
J Indian Med Assoc; 2002 Jan; 100(1):24-6. PubMed ID: 12206338
[TBL] [Abstract][Full Text] [Related]
19. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.
Hickman CJ; Hyde TB; Sowers SB; Mercader S; McGrew M; Williams NJ; Beeler JA; Audet S; Kiehl B; Nandy R; Tamin A; Bellini WJ
J Infect Dis; 2011 Jul; 204 Suppl 1():S549-58. PubMed ID: 21666212
[TBL] [Abstract][Full Text] [Related]
20. Development of an enzyme-linked immunosorbent assay for immunoglobulin M antibodies against measles virus.
Roodbari F; Roustai MH; Mostafaie A; Soleimanjdahi H; Foroshani RS; Sabahi F
Clin Diagn Lab Immunol; 2003 May; 10(3):439-42. PubMed ID: 12738645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
